Response to: The expanded role of the transplant pharmacist: A 10-year follow-up by Lichvar et al
Am J Transplant
.
2023 Dec;23(12):2011-2012.
doi: 10.1016/j.ajt.2023.07.026.
Epub 2023 Aug 11.
Authors
Angela Q Maldonado
1
,
Bharath Ravichandran
2
,
Timothy Horwedel
3
,
Kimi Ueda
4
,
Christin Rogers Marks
5
,
Matthew Everly
6
,
Erika Aldag
7
,
James Fleming
8
Affiliations
1
Hansa Biopharma AB, Lund, Sweden. Electronic address:
[email protected]
.
2
Guidehouse, Washington, DC, USA.
3
Veloxis Pharmaceuticals, Cary, North Carolina, USA.
4
Sanofi, Bridgewater, New Jersey, USA.
5
Novo Nordisk, Inc, Plainsboro, New Jersey, USA.
6
Hansa Biopharma AB, Lund, Sweden.
7
CTI Clinical Trial and Consulting, Covington, Kentucky, USA.
8
Transplant Genomics, Inc, Framingham, Massachusetts, USA.
PMID:
37573017
DOI:
10.1016/j.ajt.2023.07.026
No abstract available
Publication types
Letter
Comment
MeSH terms
Follow-Up Studies
Humans
Kidney Transplantation*
Pharmacists
Transplants*